Remote Hind Limb Ischemia Mechanism of Cardioprotection
Remote Hind Limb Ischemia Mechanism of Cardioprotection
批准号:
10438112
负责人:
Suresh C. Tyagi
金额:
$10.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30
关键词:
AddressAnti-Inflammatory AgentsAntioxidantsApoptoticAreaAttenuatedBiogenesisBiological AssayBone Marrow Stem CellBone Marrow TransplantationCardiacCoronary heart diseaseCystathionineDNADataDiabetes MellitusEndocrineEnzymesEpigenetic ProcessEventFemaleFibrosisFluorescenceFunctional disorderGasesGenesGoalsHeartHematopoietic Stem Cell MobilizationHindlimbHistologyHomocysteineHormonesHydrogen SulfideHyperhomocysteinemiaHypermethylationIncidenceInjuryIschemiaLabelLimb structureLyaseMeasuresMethylationMitochondriaModificationMouse ProteinMusMuscleMuscle functionMuscular AtrophyMyocardialMyocardial InfarctionMyocardiumNatural regenerationPPAR gammaPlasmaProceduresProductionProteinsRecoveryRiskSamplingSiteSkeletal MuscleSupplementationTestingcardioprotectionconditioningdiabeticeffective therapyexosomegene inductionglucose metabolismimprovedischemic conditioninglimb ischemiamalemitochondrial metabolismmyocardial damagemyocardial injuryresponse
中文摘要
尽管后肢远端缺血适应(RIC)具有心脏保护作用,但其机制是
未知。本项目的长期目标是了解远程保护的机制
后肢缺血。这一提议的中心假设是短暂性脑缺血发作
从心肌梗死(MI)开始,通过分泌有益于恢复的激素
来自骨骼肌内分泌的外切体,改善线粒体代谢,硫化氢
(硫化氢,一种抗氧化、抗炎、抗凋亡、血管活性气体)和骨动员
将骨髓干细胞(BMSC)移植到损伤部位(图1)。众所周知,DNA超甲基化是通过
表观遗传修饰抑制该基因并产生同型半胱氨酸(Hcy),导致
高同型半胱氨酸血症(HHcy)可降低硫化氢。有趣的是,胱硫酮β合成酶增加
(Cbs)和胱硫醚γ裂解酶(Cse)增加硫化氢,降低同型半胱氨酸。我们的预赛
数据表明,RIC诱导的肌肉抑制蛋白(一种骨骼肌激素)可以减弱心肌。
损伤和功能障碍。核心假设将通过以下三个具体目标进行检验:
具体目标1:确定RIC是否释放外切体,诱导肌肉粘连蛋白并逆转
心肌梗死和糖尿病期间骨骼肌和心肌功能受损。具体目标2:
确定RIC是否通过增加CBS和CSE的表达来促进硫化氢的产生,以及
心肌梗塞和糖尿病的表观遗传低甲基化和基因诱导。具体目标3:确定
RIC是否促使骨髓间充质干细胞动员到心肌损伤部位并减轻肌肉
糖尿病患者心肌梗死后再生所致损害。
英文摘要
Although hind limb remote ischemic conditioning (RIC) is cardioprotective, the mechanism is
unknown. The long-term goal of this project is to understand the mechanism of protection by remote
hind-limb ischemia. The central hypothesis of this proposal is that transient ischemic episodes, away
from the myocardial infarction (MI), contribute to the recovery through secretion of beneficial
exosomes from skeletal muscle endocrine, improving mitochondrial metabolism, hydrogen sulfide
(H2S, an anti-oxidant, anti-inflammatory, anti-apoptotic, vasoactive gas) and mobilization of bone
marrow stem cells (BMSC) to the site of injury (Figure 1). It is known that DNA hypermethylation by
epigenetic modification inhibits the gene and produces homocysteine (Hcy), leading to
hyperhomocysteinemia (HHcy) that decreases H2S. Interestingly, increase in cystathione β synthase
(CBS) and cystathionine γ lyase (CSE) enzymes increases H2S and decreases Hcy. Our preliminary
data suggests that RIC induced musclin (a skeletal muscle hormone) attenuated myocardial muscle
damage and dysfunction. The central hypothesis will be tested by the following three specific aims:
Specific Aim 1: To determine whether the RIC releases exosomes, induces musclin and reverses
compromised skeletal and cardiac muscle function during MI and diabetes. Specific Aim 2: To
determine whether the RIC enhances H2S production by increasing CBS and CSE expression, and
epigenetic hypomethylation and gene induction during MI and diabetes. Specific Aim 3: To determine
whether the RIC instigates BMSC mobilization to the site of myocardial injury and mitigates muscle
damage by regeneration after MI during diabetes.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fphys.2021.625780
发表时间:
2021
期刊:
Frontiers in physiology
影响因子:
4
作者:
[Stanisic D, Jeremic N, Majumder S, Pushpakumar S, George A, Singh M, Tyagi SC]
通讯作者:
Tyagi SC
Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury.
血心渗漏的机理泄漏:对1900诱导心血管损伤的影响。
DOI:
10.3390/ijms222413546
发表时间:
2021-12-17
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Homme RP, George AK, Singh M, Smolenkova I, Zheng Y, Pushpakumar S, Tyagi SC]
通讯作者:
Tyagi SC
TFAM overexpression diminishes skeletal muscle atrophy after hindlimb suspension in mice.
TFAM 过表达可减少小鼠后肢悬吊后的骨骼肌萎缩。
DOI:
10.1016/j.abb.2018.12.015
发表时间:
2019
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Theilen,NicholasT, Jeremic,Nevena, Weber,GregoryJ, Tyagi,SureshC]
通讯作者:
Tyagi,SureshC
DOI:
10.14814/phy2.15422
发表时间:
2022-08
期刊:
Physiological reports
影响因子:
2.5
作者:
[]
通讯作者:
DOI:
10.3389/fphys.2018.01268
发表时间:
2018
期刊:
Frontiers in physiology
影响因子:
4
作者:
[Homme RP, Singh M, Majumder A, George AK, Nair K, Sandhu HS, Tyagi N, Lominadze D, Tyagi SC]
通讯作者:
Tyagi SC
共 11 条
Remote Hind Limb Ischemia Mechanism of Cardioprotection
-
批准号:10247852
-
项目类别:
-
资助金额:$6.49万
-
财政年份:2020
-
负责人:Suresh C. Tyagi
-
依托单位:
Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide
-
批准号:10557832
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Remote Hind Limb Ischemia Mechanism of Cardioprotection
-
批准号:10215605
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide
-
批准号:10357570
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Reversing Skeletal Muscle Myopathy by Hydrogen Sulfide
-
批准号:10089145
-
项目类别:
-
资助金额:$32.86万
-
财政年份:2018
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8600989
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8131312
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8258238
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Mitophagic and anti-angiogenic mechanism of heart failure
-
批准号:8403722
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2011
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7408062
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7315147
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7845565
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:8076171
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7414460
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7797672
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7242879
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Mechanisms of Cerebral Vascular Remodeling
-
批准号:7624309
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Implications of Endothelial-Myocyte Uncoupling in Cardiac Arrhythmia
-
批准号:7597230
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2007
-
负责人:Suresh C. Tyagi
-
依托单位:
Inhibitor ameliorates oxidative and proteolytic strees
-
批准号:7340811
-
项目类别:
-
资助金额:$9.23万
-
财政年份:2003
-
负责人:Suresh C. Tyagi
-
依托单位:
Inhibitor ameliorates oxidative and proteolytic strees
-
批准号:7015788
-
项目类别:
-
资助金额:$2.32万
-
财政年份:2003
-
负责人:Suresh C. Tyagi
-
依托单位:
海外基金